A Banian Pharmed Product
Linagliptin
We are looking forward to your inquiry.
Description and usage
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other oral hypoglycemic agents. Linagliptin has been linked to rare instances of clinically apparent liver injury
• Pure, stable, powder form
• Good control of impurity profile by handling chemical steps in-house
• PSD tailored to FDF needs
• Technical support available on request
• Pure, stable, powder form
• Good control of impurity profile by handling chemical steps in-house
• PSD tailored to FDF needs
• Technical support available on request
Structure
General Data
IUPAC name: 8-[(3R)-3-Aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazoli-2-yl)methyl]-3,7-dihydro-1-H-purine-2,6-dione
Trade name: Tradjenta, Trajenta
Other name: BI-1356
Linagliptin
Cas no.: 668270-12-0
Molecular formula: C25H28N8O2
Molecular weight: 472.553 g/mol
Reference
IN-HOUSE